How long can a single infusion of Gilead Sciences CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, the company showed Saturday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,